M. Ezzalfani

发表

Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities

Rui Qin, Sarah Zohar, Sumithra J Mandrekar, 2013, Statistics in medicine.

Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose

X. Paoletti, T. Burzykowski, M. Ezzalfani, 2018, Journal of the Royal Statistical Society: Series C (Applied Statistics).

Dose finding with longitudinal data: simpler models, richer outcomes

X. Paoletti, R. Thiébaut, M. Ezzalfani, 2015, Statistics in medicine.

A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit From Adjuvant Platinum-Based Chemotherapy in Node-Negative Non–Small Cell Lung Cancer

P. Jänne, J. Pignon, L. Seymour, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.

S. Mathoulin-Pélissier, M. Lacroix-Triki, T. Petit, 2018, European journal of cancer.

Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial.

A. Vincent-Salomon, C. Ezzili, A. Fourquet, 2020, International journal of radiation oncology, biology, physics.

Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration

M. Gutiérrez, G. Paintaud, C. Bonneau, 2021, Clinical pharmacology and therapeutics.

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma

A. Paci, G. Le Teuff, B. Geoerger, 2020, Neuro-oncology advances.

Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study

C. Hermans, S. Aballéa, J. Pasi, 2022, Therapeutic advances in hematology.

rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B‐LONG using haemophilia‐specific quality of life questionnaires

J. Astermark, C. Hermans, E. Santagostino, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

A Bayesian dose‐finding design incorporating toxicity data from multiple treatment cycles

D. Sargent, S. Mandrekar, R. Qin, 2017, Statistics in medicine.

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

S. Mathoulin-Pélissier, B. Asselain, P. Arveux, 2019, BMJ Open.

Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfiLER study.

J. Blay, A. Viari, O. Trédan, 2017 .

Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project

S. Delaloge, D. Pérol, A. Savignoni, 2021, PloS one.

Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials.

X Paoletti, X. Paoletti, M. Ezzalfani, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Addressing the issue of bias in observational studies : Instrumental variable & Quasi-trial in ESME Research program

R. Porcher, S. Delaloge, D. Pérol, 2018 .

Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes

J. Astermark, C. Hermans, S. Barbier, 2023, Therapeutic Advances in Hematology.

[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB].

J. Gal, J. Nguyen, M. Ezzalfani, 2015, Bulletin du cancer.